Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety Study of a Cell Penetrating Peptide (p28) to Treat Solid Tumors That Resist Standard Methods of Treatment
- First Posted Date
- 2009-06-05
- Last Posted Date
- 2014-10-28
- Lead Sponsor
- Dr. Tapas K. Das Gupta
- Target Recruit Count
- 15
- Registration Number
- NCT00914914
- Locations
- 🇺🇸
University of Illinois at Chicago Department of Surgical Oncology, Chicago, Illinois, United States
News
No news found